TORONTO, Jan. 31 /CNW/ - Microbix Biosystems Inc. (TSX:MBX) announced today that it has taken over the production of its urokinase product from Genpharm Inc. and will directly operate the manufacturing facilities. The two companies, which have been working together over the past three years to commercialize the product, have now amended their licensing agreement to reflect these changes. Microbix will now assume the costs associated with bringing the drug to market - costs previously funded by Genpharm, an affiliate of Merck KgaA.
